The board of directors of CARsgen Therapeutics Holdings Limited announced that with effect from 15 August 2022, the address of the principal place of business in Hong Kong of the Company will be relocated from Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.19 HKD | -0.80% | +13.58% | -4.77% |
29/04 | CARsgen Therapeutics Holdings Limited Submits Responses to FDA Observations | CI |
12/04 | Carsgen Therapeutics To Give Cancer Drug Oral Presentation at ASCO 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 456M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- 2171 Stock
- News CARsgen Therapeutics Holdings Limited
- CARsgen Therapeutics Holdings Limited Announces Change of Address of Principal Place of Business in Hong Kong